Self-management of overactive bladder at home using transcutaneous tibial nerve stimulation: a qualitative study of women's experiences

Ciara M E Daly, Lynette Loi, Jo Booth, Dalia Saidan, Karen Guerrero, Veenu Tyagi, Ciara M E Daly, Lynette Loi, Jo Booth, Dalia Saidan, Karen Guerrero, Veenu Tyagi

Abstract

Background: Transcutaneous tibial nerve stimulation (TTNS) has been used to treat overactive bladder (OAB), however patient experiences and views of this treatment are lacking. The aim of this study was to explore women's experiences of OAB and TTNS treatment and the perceived factors influencing participation and adherence.

Methods: Semi-structured, individual interviews conducted as part of a mixed-methods, randomised, feasibility trial of self-managed versus HCP-led TTNS. Interviews were audio recorded and transcribed verbatim. Reflexive thematic analysis was undertaken using Booth et al. (Neurourol Urodynam. 2017;37:528-41) approach.

Results: 16 women were interviewed, 8 self-managing TTNS at home and 8 receiving TTNS in twice-weekly hospital clinic appointments. Women self-managing OAB considered TTNS easy to administer, flexible and favourably 'convenient', especially when the participant was bound by work and other life commitments. In contrast to OAB symptoms 'dominating life', self-managing bladder treatment was empowering and fitted around home life demands. Flexibility and control engendered by self-management, facilitated women's willingness to participate in TTNS. Women attending a hospital clinic for TTNS enjoyed the social aspects but found the routine appointments constrained their lives. Motivation to continue TTNS in the longer term was dependent on perception of benefit.

Conclusions: This study provides novel insights into women's experiences of self-managing their OAB using TTNS compared to HCP-led management in the clinical setting. It highlights positive experiences self-managing TTNS at home and a willingness to continue in the longer term, facilitated by ease of use and convenience. Trial Registration 1/11/2018: ClinicalTrials.gov Identifier: NCT03727711.

Keywords: Overactive; Qualitative research; Tibial nerve stimulation; Transcutaneous electric nerve stimulation; Urinary bladder.

Conflict of interest statement

The authors declare that they have no competing interests.

© 2021. The Author(s).

Figures

Fig. 1
Fig. 1
The NeuroTrac Continence machine stimulation parameters and surface electrode positioning

References

    1. Haylen BT, et al. An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction. Int Urogynecol J. 2009;21:5–26. doi: 10.1007/s00192-009-0976-9.
    1. Sexton CC, et al. Persistence and adherence in the treatment of overactive bladder syndrome with anticholinergic therapy: a systematic review of the literature. Int J Clin Pract. 2011;65:567–585. doi: 10.1111/j.1742-1241.2010.02626.x.
    1. Craggs M, McFarlane J. Neuromodulation of the lower urinary tract. Exp Physiol. 1999;84:149–160. doi: 10.1111/j.1469-445X.1999.tb00080.x.
    1. Booth J, Connelly L, Dickson S, Duncan F, Lawrence M. The effectiveness of transcutaneous tibial nerve stimulation (TTNS) for adults with overactive bladder syndrome: a systematic review. Neurourol Urodynam. 2017;37:528–541. doi: 10.1002/nau.23351.
    1. Robinson D, Jacklin P, Cardozo L. Is cost the Achilles’ heel of posterior tibial nerve stimulation? A cost minimisation comparison with antimuscarinic therapy in the management of OAB. International Continence Society Conference Abstracts, 2009. (n.d.).
    1. Martin-Garcia M, Crampton J. A single-blind, randomized controlled trial to evaluate the effectiveness of transcutaneous tibial nerve stimulation (TTNS) in Overactive Bladder symptoms in women responders to percutaneous tibial nerve stimulation (PTNS) Physiotherapy. 2019;105:469–475. doi: 10.1016/j.physio.2018.12.002.
    1. Sönmez R, Yıldız N, Alkan H. Efficacy of percutaneous and transcutaneous tibial nerve stimulation in women with idiopathic overactive bladder: a prospective randomised controlled trial. Ann Phys Rehabil Med. 2021;8:101486. doi: 10.1016/j.rehab.2021.101486.
    1. Peters KM, et al. Sustained therapeutic effects of percutaneous tibial nerve stimulation: 24-month results of the STEP study. Neurourol Urodynam. 2013;32:24–29. doi: 10.1002/nau.22266.
    1. Booth J, et al. ELECtric Tibial nerve stimulation to Reduce Incontinence in Care homes: protocol for the ELECTRIC randomised trial. Trials. 2019;20:723. doi: 10.1186/s13063-019-3723-7.
    1. Archer M, et al. What is critical realism? Perspectives: a newsletter of the ASA theory. (2017). Accessed 18 April 2021.
    1. Amarenco G, et al. Urodynamic effect of acute transcutaneous posterior tibial nerve stimulation in overactive bladder. J Urol. 2003;169:2210–2215. doi: 10.1097/.
    1. Braun V, Clarke V. Reflecting on reflexive thematic analysis. Qual Res Sport Exer Health. 2019;11:589–597. doi: 10.1080/2159676X.2019.1628806.
    1. Jin J, Sklar G, Oh V, Li S. Factors affecting therapeutic compliance: a review from the patient’s perspective. Ther Clin Risk Manag. 2008;4:269–286. doi: 10.2147/TCRM.S1458.
    1. Kyngas H. Predictors of good compliance in adolescents with epilepsy. Seizure. 2001;10:549–553. doi: 10.1053/seiz.2001.0557.
    1. Loffler W, Kilian R, Toumi M. Schizophrenic patients' subjective reasons for compliance and noncompliance with neuroleptic treatment. Pharmacopsychiatry. 2003;36:105–112. doi: 10.1055/s-2003-39985.
    1. Thomas LK, Sargent RG, Michels PC. Identification of the factors associated with compliance to therapeutic diets in older adults with end stage renal disease. J Ren Nutr. 2001;11:80–89. doi: 10.1016/S1051-2276(01)98615-7.
    1. Voils CI, Steffens DC, Flint EP. Social support and locus of control as predictors of adherence to antidepressant medication in an elderly population. Am J Geriatr Psychiatry. 2005;13:157–165. doi: 10.1097/00019442-200502000-00010.
    1. Ellis J, et al. Suboptimal statin adherence and discontinuation in primary and secondary prevention populations. J Gen Intern Med. 2004;19:638–645. doi: 10.1111/j.1525-1497.2004.30516.x.

Source: PubMed

Sponsorer og samarbejdspartnere

Medicinske tilstande

Narkotikainterventioner

3
Abonner